The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
RTOG 0525: Molecular correlates from a randomized phase III trial of newly diagnosed glioblastoma.
K. D. Aldape
Honoraria - Sontag Foundation; University of Toronto
Research Funding - American College of Radiology
M. Wang
No relevant relationships to disclose
E. P. Sulman
No relevant relationships to disclose
M. Hegi
Consultant or Advisory Role - MDxHealth
Honoraria - Merck Sharp & Dohme
Research Funding - MDxHealth; Schering-Plough
D. P. Cahill
No relevant relationships to disclose
H. Colman
Consultant or Advisory Role - Castle Biosciences; Schering-Plough
G. Jones
Employment or Leadership Position - MDxHealth
A. Chakravarti
No relevant relationships to disclose
M. P. Mehta
Employment or Leadership Position - Pharmacyclics
Consultant or Advisory Role - Genentech; Merck; Tomotherapy
Stock Ownership - Pharmacyclics; Tomotherapy
Honoraria - Merck
D. W. Andrews
Consultant or Advisory Role - BrainLAB
Honoraria - BrainLAB
L. Long
No relevant relationships to disclose
K. Diefes
No relevant relationships to disclose
L. Heathcock
No relevant relationships to disclose
R. Jenkins
No relevant relationships to disclose
C. J. Schultz
No relevant relationships to disclose
M. R. Gilbert
Consultant or Advisory Role - Genentech; Sigma-Tau
Honoraria - Genentech; Merck; Sigma-Tau
Research Funding - Genentech; Merck